| 1 | Identification of Clinical Drivers of Left Atrial Enlargement Through Genomics of Left Atrial Size | 5.4 | 4 | Citations (PDF) |
| 2 | Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations | 39.5 | 149 | Citations (PDF) |
| 3 | Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization | 3.3 | 23 | Citations (PDF) |
| 4 | Effect of clinical decision support for severe hypercholesterolemia on low-density lipoprotein cholesterol levels | 10.7 | 7 | Citations (PDF) |
| 5 | Clinical associations with a polygenic predisposition to benign lower white blood cell counts | 13.9 | 7 | Citations (PDF) |
| 6 | Polygenic Risk and Coronary Artery Disease Severity | 3.3 | 1 | Citations (PDF) |
| 7 | Familial Hypercholesterolemia in the Electronic Medical Records and Genomics Network: Prevalence, Penetrance, Cardiovascular Risk, and Outcomes After Return of Results | 3.3 | 15 | Citations (PDF) |
| 8 | Daytime Versus Nighttime Ambulatory Blood Pressure Monitoring in Coarctation of Aorta | 6.9 | 3 | Citations (PDF) |
| 9 | Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease | 4.9 | 6 | Citations (PDF) |
| 10 | Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms | 13.9 | 17 | Citations (PDF) |
| 11 | Principles and methods for transferring polygenic risk scores across global populations | 47.6 | 243 | Citations (PDF) |
| 12 | A linear weighted combination of polygenic scores for a broad range of traits improves prediction of coronary heart disease | 3.2 | 12 | Citations (PDF) |
| 13 | Genome-wide association meta-analysis identifies risk loci for abdominal aortic aneurysm and highlights PCSK9 as a therapeutic target | 26.1 | 78 | Citations (PDF) |
| 14 | Deep generative models of LDLR protein structure to predict variant pathogenicity | 3.7 | 4 | Citations (PDF) |
| 15 | Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease | 13.9 | 53 | Citations (PDF) |
| 16 | Penalized mediation models for multivariate data | 3.1 | 6 | Citations (PDF) |
| 17 | Do research participants share genomic screening results with family members? | 1.7 | 25 | Citations (PDF) |
| 18 | Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation | 2.5 | 12 | Citations (PDF) |
| 19 | Clinical Applications Measuring Arterial Stiffness: An Expert Consensus for the Application of Cardio-Ankle Vascular Index | 2.0 | 55 | Citations (PDF) |
| 20 | Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen | 3.7 | 20 | Citations (PDF) |
| 21 | Under-specification as the source of ambiguity and vagueness in narrative phenotype algorithm definitions | 3.3 | 5 | Citations (PDF) |
| 22 | Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid | 3.0 | 12 | Citations (PDF) |
| 23 | The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network | 4.3 | 23 | Citations (PDF) |
| 24 | Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study | 25.2 | 40 | Citations (PDF) |
| 25 | Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study | 4.3 | 59 | Citations (PDF) |
| 26 | Genome-wide polygenic score to predict chronic kidney disease across ancestries | 39.5 | 144 | Citations (PDF) |
| 27 | Large-scale genomic analyses reveal insights into pleiotropy across circulatory system diseases and nervous system disorders | 13.9 | 19 | Citations (PDF) |
| 28 | Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations | 3.0 | 20 | Citations (PDF) |
| 29 | Pathogenic variants in arteriopathy genes detected in a targeted sequencing study: Penetrance and 1-year outcomes after return of results | 4.3 | 0 | Citations (PDF) |
| 30 | Large-scale genome-wide association study of coronary artery disease in genetically diverse populations | 39.5 | 302 | Citations (PDF) |
| 31 | A pragmatic clinical trial of cascade testing for familial hypercholesterolemia | 4.3 | 14 | Citations (PDF) |
| 32 | The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US | 2.9 | 19 | Citations (PDF) |
| 33 | Validation of Polygenic Risk Scores for Coronary Heart Disease in a Middle Eastern Cohort Using Whole Genome Sequencing | 3.3 | 10 | Citations (PDF) |
| 34 | Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure | 13.9 | 129 | Citations (PDF) |
| 35 | Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants | 26.1 | 597 | Citations (PDF) |
| 36 | Returning negative results from <scp>large‐scale</scp> genomic screening: Experiences from the <scp>eMERGE III</scp> network | 1.5 | 10 | Citations (PDF) |
| 37 | Loci identified by a genome‐wide association study of carotid artery stenosis in the eMERGE network | 3.1 | 9 | Citations (PDF) |
| 38 | Association between triglycerides, known risk SNVs and conserved rare variation in SLC25A40 in a multi-ancestry cohort | 1.8 | 4 | Citations (PDF) |
| 39 | Usability of a Digital Registry to Promote Secondary Prevention for Peripheral Artery Disease Patients | 2.0 | 3 | Citations (PDF) |
| 40 | “Who Doesn’t Like Receiving Good News?” Perspectives of Individuals Who Received Genomic Screening Results by Mail | 2.6 | 2 | Citations (PDF) |
| 41 | Penetrance and outcomes at 1-year following return of actionable variants identified by genome sequencing | 4.3 | 4 | Citations (PDF) |
| 42 | Genetic basis of hypercholesterolemia in adults | 4.3 | 32 | Citations (PDF) |
| 43 | Preferences for Updates on General Research Results: A Survey of Participants in Genomic Research from Two Institutions | 2.6 | 6 | Citations (PDF) |
| 44 | Familial hypercholesterolemia in Southeast and East Asia | 2.9 | 14 | Citations (PDF) |
| 45 | A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts | 26.1 | 22 | Citations (PDF) |
| 46 | Leveraging the Electronic Health Record to Address the COVID-19 Pandemic | 3.1 | 30 | Citations (PDF) |
| 47 | Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population‐Based Study | 4.3 | 26 | Citations (PDF) |
| 48 | Quantitative disease risk scores from EHR with applications to clinical risk stratification and genetic studies | 10.7 | 14 | Citations (PDF) |
| 49 | Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry | 3.3 | 33 | Citations (PDF) |
| 50 | Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis | 2.9 | 26 | Citations (PDF) |
| 51 | Increasing access to individualized medicine: a matched-cohort study examining Latino participant experiences of genomic screening | 4.3 | 9 | Citations (PDF) |
| 52 | Integrating Genomic Screening into Primary Care: Provider Experiences Caring for Latino Patients at a Community-Based Health Center | 2.1 | 10 | Citations (PDF) |
| 53 | Genome-Wide Association Study of Peripheral Artery Disease | 3.3 | 72 | Citations (PDF) |
| 54 | Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases | 13.9 | 63 | Citations (PDF) |
| 55 | Integrating pharmacogenomics into the electronic health record by implementing genomic indicators | 3.6 | 45 | Citations (PDF) |
| 56 | “They’re Not Going to Do Nothing for Me”: Research Participants’ Attitudes towards Elective Genetic Counseling | 2.6 | 3 | Citations (PDF) |
| 57 | Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program | 25.2 | 132 | Citations (PDF) |
| 58 | Patient reactions to receiving negative genomic screening results by mail | 4.3 | 7 | Citations (PDF) |
| 59 | Challenges in returning results in a genomic medicine implementation study: the Return of Actionable Variants Empirical (RAVE) study | 4.3 | 10 | Citations (PDF) |
| 60 | Participant choices for return of genomic results in the eMERGE Network | 4.3 | 33 | Citations (PDF) |
| 61 | Using the electronic health record for genomics research | 4.1 | 8 | Citations (PDF) |
| 62 | An Implementation Science Framework to Develop a Clinical Decision Support Tool for Familial Hypercholesterolemia | 2.6 | 20 | Citations (PDF) |
| 63 | Returning genomic results in a Federally Qualified Health Center: the intersection of precision medicine and social determinants of health | 4.3 | 31 | Citations (PDF) |
| 64 | Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease: A Mendelian Randomization Study | 4.3 | 29 | Citations (PDF) |
| 65 | Understanding the Return of Genomic Sequencing Results Process: Content Review of Participant Summary Letters in the eMERGE Research Network | 2.6 | 17 | Citations (PDF) |
| 66 | Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network | 2.6 | 44 | Citations (PDF) |
| 67 | Frequency of genomic secondary findings among 21,915 eMERGE network participants | 4.3 | 99 | Citations (PDF) |
| 68 | Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups | 6.5 | 129 | Citations (PDF) |
| 69 | Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) study | 3.3 | 32 | Citations (PDF) |
| 70 | Sex-specific associations of inflammation markers with cognitive decline | 3.8 | 14 | Citations (PDF) |
| 71 | Neutral, Negative, or Negligible? Changes in Patient Perceptions of Disease Risk Following Receipt of a Negative Genomic Screening Result | 2.6 | 7 | Citations (PDF) |
| 72 | Failure to follow up on a medically actionable finding from direct to consumer genetic testing: A case report | 1.6 | 2 | Citations (PDF) |
| 73 | Evaluation of the MC4R gene across eMERGE network identifies many unreported obesity-associated variants | 3.2 | 36 | Citations (PDF) |
| 74 | Deploying Clinical Decision Support for Familial Hypercholesterolemia | 0.2 | 4 | Citations (PDF) |
| 75 | Discovering novel biochemical and genetic markers for coronary heart disease in Qatari individuals: The initiative Qatar cardiovascular biorepository | 0.5 | 10 | Citations (PDF) |
| 76 | Facilitating phenotype transfer using a common data model | 3.8 | 63 | Citations (PDF) |
| 77 | Making work visible for electronic phenotype implementation: Lessons learned from the eMERGE network | 3.8 | 29 | Citations (PDF) |
| 78 | New Case Detection by Cascade Testing in Familial Hypercholesterolemia | 3.3 | 59 | Citations (PDF) |
| 79 | Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry | 1.6 | 74 | Citations (PDF) |
| 80 | Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network | 6.5 | 115 | Citations (PDF) |
| 81 | Electronic health record access by patients as an indicator of information seeking and sharing for cardiovascular health promotion in social networks: Secondary analysis of a randomized clinical trial | 1.7 | 1 | Citations (PDF) |
| 82 | Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association | 3.3 | 106 | Citations (PDF) |
| 83 | Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease—Brief Report | 6.3 | 15 | Citations (PDF) |
| 84 | Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth Rates | 3.3 | 60 | Citations (PDF) |
| 85 | A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR | 4.3 | 30 | Citations (PDF) |
| 86 | Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study | 3.9 | 25 | Citations (PDF) |
| 87 | Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection | 2.4 | 180 | Citations (PDF) |
| 88 | Natural language processing of clinical notes for identification of critical limb ischemia | 3.4 | 93 | Citations (PDF) |
| 89 | Innovative Informatics Approaches for Peripheral Artery Disease: Current State and Provider Survey of Strategies for Improving Guideline-Based Care | 2.0 | 14 | Citations (PDF) |
| 90 | <i>LPA</i>
Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins | 25.2 | 85 | Citations (PDF) |
| 91 | Burden of hospitalization in clinically diagnosed peripheral artery disease: A community-based study | 3.0 | 15 | Citations (PDF) |
| 92 | Patient and Provider Perspectives on a Decision Aid for Familial Hypercholesterolemia | 2.6 | 10 | Citations (PDF) |
| 93 | The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results | 3.1 | 33 | Citations (PDF) |
| 94 | Leveraging the Electronic Health Record to Create an Automated Real‐Time Prognostic Tool for Peripheral Arterial Disease | 4.3 | 27 | Citations (PDF) |
| 95 | Association of Ankle-Brachial Indices With Limb Revascularization or Amputation in Patients With Peripheral Artery Disease | 6.8 | 25 | Citations (PDF) |
| 96 | Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience | 2.6 | 48 | Citations (PDF) |
| 97 | Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study | 2.6 | 10 | Citations (PDF) |
| 98 | Adverse effects of long-term weight gain on microvascular endothelial function | 1.6 | 10 | Citations (PDF) |
| 99 | A Clinical Decision Support Tool for Familial Hypercholesterolemia Based on Physician Input | 2.0 | 19 | Citations (PDF) |
| 100 | Empowering genomic medicine by establishing critical sequencing result data flows: the eMERGE example | 3.6 | 26 | Citations (PDF) |
| 101 | Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study | 3.3 | 24 | Citations (PDF) |
| 102 | Shared Decision-Making following Disclosure of Coronary Heart Disease Genetic Risk: Results from a Randomized Clinical Trial | 1.9 | 27 | Citations (PDF) |
| 103 | Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals | 3.2 | 13 | Citations (PDF) |
| 104 | Mining peripheral arterial disease cases from narrative clinical notes using natural language processing | 1.8 | 98 | Citations (PDF) |
| 105 | Disclosing Genetic Risk for Coronary Heart Disease: Attitudes Toward Personal Information in Health Records | 3.3 | 13 | Citations (PDF) |
| 106 | Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci | 12.5 | 209 | Citations (PDF) |
| 107 | Precision Cardiovascular Medicine: State of Genetic Testing | 3.1 | 59 | Citations (PDF) |
| 108 | Sex differences in associations of cardio-ankle vascular index with left ventricular function and geometry | 3.0 | 8 | Citations (PDF) |
| 109 | Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing | 3.9 | 34 | Citations (PDF) |
| 110 | Motivation, Perception, and Treatment Beliefs in the Myocardial Infarction Genes (MI‐GENES) Randomized Clinical Trial | 1.7 | 4 | Citations (PDF) |
| 111 | A <i>Dab2Ip</i> Genotype: Sex Interaction is Associated with Abdominal Aortic Aneurysm Expansion | 1.9 | 7 | Citations (PDF) |
| 112 | Multidisciplinary model to implement pharmacogenomics at the point of care | 4.3 | 92 | Citations (PDF) |
| 113 | Genome-wide study of resistant hypertension identified from electronic health records | 2.4 | 38 | Citations (PDF) |
| 114 | Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial | 2.4 | 46 | Citations (PDF) |
| 115 | Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study | 3.2 | 104 | Citations (PDF) |
| 116 | My Approach to the Patient With Familial Hypercholesterolemia | 3.1 | 39 | Citations (PDF) |
| 117 | Peripheral Artery Disease | 43.7 | 275 | Citations (PDF) |
| 118 | A multi-locus genetic risk score for abdominal aortic aneurysm | 1.6 | 14 | Citations (PDF) |
| 119 | Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates | 25.2 | 250 | Citations (PDF) |
| 120 | Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records | 17.1 | 159 | Citations (PDF) |
| 121 | Family history of atherosclerotic vascular disease is associated with the presence of abdominal aortic aneurysm | 3.0 | 8 | Citations (PDF) |
| 122 | Sex Differences in the Associations of Hemodynamic Load With Left Ventricular Hypertrophy and Concentric Remodeling | 2.0 | 40 | Citations (PDF) |
| 123 | Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing | 2.4 | 8 | Citations (PDF) |
| 124 | PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance | 3.3 | 179 | Citations (PDF) |
| 125 | Associations of Alterations in Pulsatile Arterial Load With Left Ventricular Longitudinal Strain | 2.0 | 18 | Citations (PDF) |
| 126 | A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals | 0.9 | 6 | Citations (PDF) |
| 127 | The Genetic Basis of Peripheral Arterial Disease | 12.5 | 83 | Citations (PDF) |
| 128 | Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network | 6.5 | 61 | Citations (PDF) |
| 129 | A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease | 26.1 | 2,461 | Citations (PDF) |
| 130 | Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin Therapy | 2.4 | 21 | Citations (PDF) |
| 131 | Practical considerations in genomic decision support: The eMERGE experience | 2.3 | 45 | Citations (PDF) |
| 132 | Genetic Variants Associated with Serum Thyroid Stimulating Hormone (TSH) Levels in European Americans and African Americans from the eMERGE Network | 2.4 | 40 | Citations (PDF) |
| 133 | Return of results in the genomic medicine projects of the eMERGE network | 2.4 | 43 | Citations (PDF) |
| 134 | Whole Exome Sequencing Implicates an
<i>INO80D</i>
Mutation in a Syndrome of Aortic Hypoplasia, Premature Atherosclerosis, and Arterial Stiffness | 3.9 | 26 | Citations (PDF) |
| 135 | The ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study | 2.4 | 47 | Citations (PDF) |
| 136 | eMERGEing progress in genomics—the first seven years | 2.4 | 81 | Citations (PDF) |
| 137 | Phenome-wide association studies demonstrating pleiotropy of genetic variants within FTO with and without adjustment for body mass index | 2.4 | 71 | Citations (PDF) |
| 138 | Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right Dose, Right Time—Using Genomic Data to Individualize Treatment Protocol | 3.1 | 281 | Citations (PDF) |
| 139 | Arterial stiffness is associated with increase in blood pressure over time in treated hypertensives | 2.5 | 34 | Citations (PDF) |
| 140 | Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between | 6.5 | 366 | Citations (PDF) |
| 141 | Family History as a Risk Factor for Carotid Artery Stenosis | 6.0 | 18 | Citations (PDF) |
| 142 | Family History as a Risk Factor for Peripheral Arterial Disease | 1.9 | 33 | Citations (PDF) |
| 143 | The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future | 4.3 | 687 | Citations (PDF) |
| 144 | Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data | 32.2 | 1,014 | Citations (PDF) |
| 145 | Ethical, legal, and social implications of incorporating genomic information into electronic health records | 4.3 | 92 | Citations (PDF) |
| 146 | Genome- and Phenome-Wide Analyses of Cardiac Conduction Identifies Markers of Arrhythmia Risk | 25.2 | 176 | Citations (PDF) |
| 147 | Sex Differences in Arterial Stiffness and Ventricular-Arterial Interactions | 2.4 | 272 | Citations (PDF) |
| 148 | Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy | 1.6 | 47 | Citations (PDF) |
| 149 | A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm | 3.0 | 96 | Citations (PDF) |
| 150 | Ethnic differences in ankle brachial index are present in middle-aged individuals without peripheral arterial disease | 2.3 | 11 | Citations (PDF) |
| 151 | Disease Location Is Associated With Survival in Patients With Peripheral Arterial Disease | 4.3 | 55 | Citations (PDF) |
| 152 | Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network | 3.6 | 379 | Citations (PDF) |
| 153 | Billing code algorithms to identify cases of peripheral artery disease from administrative data | 3.6 | 98 | Citations (PDF) |
| 154 | Genetic Variants That Confer Resistance to Malaria Are Associated with Red Blood Cell Traits in African-Americans: An Electronic Medical Record-based Genome-Wide Association Study | 2.0 | 36 | Citations (PDF) |
| 155 | Associations of Candidate Biomarkers of Vascular Disease with the Ankle-Brachial Index and Peripheral Arterial Disease | 2.0 | 34 | Citations (PDF) |
| 156 | An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease | 0.3 | 20 | Citations (PDF) |
| 157 | A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury | 3.6 | 66 | Citations (PDF) |
| 158 | Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record–Linked Genome-Wide Association Study | 0.7 | 3 | Citations (PDF) |
| 159 | Enhancing the Power of Genetic Association Studies through the Use of Silver Standard Cases Derived from Electronic Medical Records | 2.4 | 23 | Citations (PDF) |
| 160 | A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects | 3.0 | 141 | Citations (PDF) |
| 161 | Biomarkers Associated With Pulse Pressure in African-Americans and Non-Hispanic Whites | 2.0 | 22 | Citations (PDF) |
| 162 | High Density GWAS for LDL Cholesterol in African Americans Using Electronic Medical Records Reveals a Strong Protective Variant in <i>APOE</i> | 2.8 | 45 | Citations (PDF) |
| 163 | Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies | 3.9 | 111 | Citations (PDF) |
| 164 | Genetics of Peripheral Artery Disease | 25.2 | 68 | Citations (PDF) |
| 165 | Survival in Patients With Poorly Compressible Leg Arteries | 2.4 | 75 | Citations (PDF) |
| 166 | Genetic Loci Implicated in Erythroid Differentiation and Cell Cycle Regulation Are Associated With Red Blood Cell Traits | 3.1 | 49 | Citations (PDF) |
| 167 | Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease | 3.8 | 43 | Citations (PDF) |
| 168 | Mayo Genome Consortia: A Genotype-Phenotype Resource for Genome-Wide Association Studies With an Application to the Analysis of Circulating Bilirubin Levels | 3.1 | 69 | Citations (PDF) |
| 169 | Aortic Pulse Wave Velocity Is Associated With Measures of Subclinical Target Organ Damage | 7.0 | 111 | Citations (PDF) |
| 170 | Quality Control Procedures for Genome‐Wide Association Studies | 1.6 | 296 | Citations (PDF) |
| 171 | Risk factor profile for chronic kidney disease is similar to risk factor profile for small artery disease | 2.3 | 13 | Citations (PDF) |
| 172 | Variants Near FOXE1 Are Associated with Hypothyroidism and Other Thyroid Conditions: Using Electronic Medical Records for Genome- and Phenome-wide Studies | 6.5 | 242 | Citations (PDF) |
| 173 | Genotype-informed estimation of risk of coronary heart disease based on genome-wide association data linked to the electronic medical record | 2.2 | 39 | Citations (PDF) |
| 174 | Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease | 2.0 | 49 | Citations (PDF) |
| 175 | Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality | 3.1 | 84 | Citations (PDF) |
| 176 | Increased Serum N-Terminal Pro–B-Type Natriuretic Peptide Levels in Patients With Medial Arterial Calcification and Poorly Compressible Leg Arteries | 6.3 | 24 | Citations (PDF) |
| 177 | A Bivariate Genome-Wide Approach to Metabolic Syndrome | 4.4 | 241 | Citations (PDF) |
| 178 | Arterial dysfunction and functional performance in patients with peripheral artery disease: A review | 3.0 | 46 | Citations (PDF) |
| 179 | Sex and Ethnic Differences in 47 Candidate Proteomic Markers of Cardiovascular Disease: The Mayo Clinic Proteomic Markers of Arteriosclerosis Study | 2.4 | 80 | Citations (PDF) |
| 180 | A Genome-Wide Association Study of Red Blood Cell Traits Using the Electronic Medical Record | 2.4 | 110 | Citations (PDF) |
| 181 | Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease | 3.6 | 137 | Citations (PDF) |
| 182 | Antibody-Based Protein Multiplex Platforms: Technical and Operational Challenges | 1.1 | 295 | Citations (PDF) |
| 183 | Early identification of cardiovascular risk using genomics and proteomics | 37.5 | 65 | Citations (PDF) |
| 184 | Measurement and Quality Control Issues in Multiplex Protein Assays: A Case Study | 1.1 | 66 | Citations (PDF) |
| 185 | Plasma Midregional Pro-atrial Natriuretic Peptide Is Associated With Blood Pressure Indices and Hypertension Severity in Adults With Hypertension | 2.0 | 22 | Citations (PDF) |
| 186 | Genome-Wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors | 3.9 | 48 | Citations (PDF) |
| 187 | Evolutionary Genetics of Coronary Heart Disease | 25.2 | 37 | Citations (PDF) |
| 188 | Mid-Regional Pro-Adrenomedullin Is Associated With Pulse Pressure, Left Ventricular Mass, and Albuminuria in African Americans With Hypertension | 2.0 | 15 | Citations (PDF) |
| 189 | Relation of Plasma Midregional Proatrial Natriuretic Peptide to Target Organ Damage in Adults With Systemic Hypertension | 1.9 | 15 | Citations (PDF) |
| 190 | Complexity in the genetic architecture of leukoaraiosis in hypertensive sibships from the GENOA Study | 1.8 | 42 | Citations (PDF) |
| 191 | Brachial-ankle pulse wave velocity is associated with walking distance in patients referred for peripheral arterial disease evaluation | 1.6 | 34 | Citations (PDF) |
| 192 | C-reactive protein among community-dwelling hypertensives on single-agent antihypertensive treatment | 2.5 | 17 | Citations (PDF) |
| 193 | Investigating the complex genetic architecture of ankle-brachial index, a measure of peripheral arterial disease, in non-Hispanic whites | 1.8 | 23 | Citations (PDF) |
| 194 | Association of polymorphisms in NOS3 with the ankle-brachial index in hypertensive adults | 1.6 | 32 | Citations (PDF) |
| 195 | Chapter 8 Atherogenic Lipoprotein Subprofiling | 3.4 | 10 | Citations (PDF) |
| 196 | Association of Soluble Cell Adhesion Molecules with Ankle-Brachial Index in a Biethnic Cohort of Predominantly Hypertensive Individuals | 1.1 | 6 | Citations (PDF) |
| 197 | Forearm Vascular Reactivity and Arterial Stiffness in Asymptomatic Adults From the Community | 6.9 | 38 | Citations (PDF) |
| 198 | Molecular population genetics of PCSK9: a signature of recent positive selection | 1.3 | 45 | Citations (PDF) |
| 199 | Genetic markers of vascular aging | 1.6 | 0 | Citations (PDF) |
| 200 | Markers of inflammation are inversely associated with V̇o2 max in asymptomatic men | 2.9 | 108 | Citations (PDF) |
| 201 | Brachial artery diameter and vasodilator response to nitroglycerine, but not flow-mediated dilatation, are associated with the presence and quantity of coronary artery calcium in asymptomatic adults | 6.4 | 56 | Citations (PDF) |
| 202 | Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions | 1.3 | 21 | Citations (PDF) |
| 203 | Association of Novel Risk Factors With the Ankle Brachial Index in African American and Non-Hispanic White Populations | 3.1 | 28 | Citations (PDF) |
| 204 | Associations of Serum Uric Acid With Markers of Inflammation, Metabolic Syndrome, and Subclinical Coronary Atherosclerosis | 2.0 | 155 | Citations (PDF) |
| 205 | Association of Cardiovascular Risk Factors with Microvascular and Conduit Artery Function in Hypertensive Subjects | 2.0 | 20 | Citations (PDF) |
| 206 | Measures of arterial stiffness and wave reflection are associated with walking distance in patients with peripheral arterial disease | 1.6 | 52 | Citations (PDF) |
| 207 | Aortic augmentation index is associated with the ankle-brachial index: A community-based study | 1.6 | 42 | Citations (PDF) |
| 208 | Association of Novel Risk Factors With the Ankle Brachial Index in African American and Non-Hispanic White Populations | 3.1 | 28 | Citations (PDF) |
| 209 | Arterial Ultrasonography and Tonometry as Adjuncts to Cardiovascular Risk Stratification | 2.4 | 121 | Citations (PDF) |
| 210 | Ethnic differences in low-density lipoprotein particle size in hypertensive adults | 3.2 | 12 | Citations (PDF) |
| 211 | Patterns of population differentiation of candidate genes for cardiovascular disease | 2.9 | 35 | Citations (PDF) |
| 212 | Mechanisms of Disease: the genetic basis of coronary heart disease | 0.0 | 73 | Citations (PDF) |
| 213 | Evidence for Positive Selection in the C-terminal Domain of the Cholesterol Metabolism Gene PCSK9 Based on Phylogenetic Analysis in 14 Primate Species | 2.4 | 19 | Citations (PDF) |
| 214 | A genome-wide linkage scan for ankle–brachial index in African American and non-Hispanic white subjects participating in the GENOA study | 1.6 | 51 | Citations (PDF) |
| 215 | Association of Plasma Homocysteine With Coronary Artery Calcification in Different Categories of Coronary Heart Disease Risk | 3.1 | 30 | Citations (PDF) |
| 216 | Aortic Augmentation Index Is Inversely Associated With Cardiorespiratory Fitness in Men Without Known Coronary Heart Disease | 2.0 | 49 | Citations (PDF) |
| 217 | Molecular evolution of 5′ flanking regions of 87 candidate genes for atherosclerotic cardiovascular disease | 3.1 | 11 | Citations (PDF) |
| 218 | Novel Genomic Loci Influencing Plasma Homocysteine Levels | 6.0 | 23 | Citations (PDF) |
| 219 | Quantitative trait loci influencing low density lipoprotein particle size in African Americans | 3.7 | 10 | Citations (PDF) |
| 220 | Aortic Pulse Wave Velocity Is Associated With the Presence and Quantity of Coronary Artery Calcium | 6.9 | 88 | Citations (PDF) |
| 221 | Methods for the selection of tagging SNPs: a comparison of tagging efficiency and performance | 3.2 | 35 | Citations (PDF) |
| 222 | Conditional Risk Factors for Atherosclerosis | 3.1 | 83 | Citations (PDF) |
| 223 | Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships | 2.0 | 27 | Citations (PDF) |
| 224 | A Novel Quantitative Trait Locus on Chromosome 1 with Pleiotropic Effects on HDL-Cholesterol and LDL Particle Size in Hypertensive Sibships | 2.0 | 17 | Citations (PDF) |
| 225 | C-Reactive Protein Is Related to Arterial Wave Reflection and Stiffness in Asymptomatic Subjects From the Community | 2.0 | 93 | Citations (PDF) |
| 226 | Lack of Association Between Lipoprotein(a) and Coronary Artery Calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) Study | 3.1 | 28 | Citations (PDF) |
| 227 | Low-density lipoprotein particle size and coronary atherosclerosis in subjects belonging to hypertensive sibships | 2.0 | 9 | Citations (PDF) |
| 228 | Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location | 3.0 | 38 | Citations (PDF) |
| 229 | Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study | 3.0 | 135 | Citations (PDF) |
| 230 | Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, ≥30) | 1.9 | 81 | Citations (PDF) |
| 231 | Relation of low cardiorespiratory fitness to the metabolic syndrome in middle-aged men | 1.9 | 47 | Citations (PDF) |
| 232 | Novel Risk Factors for Atherosclerosis | 3.1 | 146 | Citations (PDF) |
| 233 | Adenovirus-Mediated Gene Transfer of Macrophage Colony Stimulating Factor to the Arterial Wall In Vivo | 6.3 | 22 | Citations (PDF) |
| 234 | Vulnerable Plaque: Pathobiology and Clinical Implications | 10.4 | 177 | Citations (PDF) |
| 235 | Enhanced Endothelium-Dependent Relaxations After Gene Transfer of Recombinant Endothelial Nitric Oxide Synthase to Rabbit Carotid Arteries | 6.9 | 62 | Citations (PDF) |
| 236 | Promise and Peril of a Genotype‐First Approach to Mendelian Cardiovascular Disease | 4.3 | 8 | Citations (PDF) |
